speb/financial-data huggingface dataset:
MD — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1756587676.29
Net income (USD): 33683000
P/E ratio: 10.621010449911722
P/B ratio: 2.0287342626932485
Pays dividend: no
Net asset value (USD): -411740000
Net cash (USD): -881119000
Net cash to market cap %: -50.16083238503454
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.1742282959788457 (Distress Zone)
Piotroski F-score: 5 (Neutral)
MD — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Turnaround (confidence: High)
Market cap (USD): 2156521472
Net income (USD): 29572000
EPS growth %: 42.60500554564305
Revenue growth %: 3.8914911674037165
Smoothed growth %: 42.60500554564305
P/E ratio: 10.383495145631068
P/B ratio: 1.9993576836722151
PEG ratio: 0.2437153806847215
Pays dividend: no
Net asset value (USD): -405609000
Net cash (USD): -862745000
Net cash to market cap %: -40.00632552013839
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.43747611263999 (Distress Zone)
Piotroski F-score: 3 (Weak)
MDA.TO — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Industrials | Industry: Aerospace & Defense
Lynch category:  (confidence: Low)
Market cap (USD): 1211206172.8346457
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
MDA.TO — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Industrials | Industry: Aerospace & Defense
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 761972428.2352941
Net income (USD): 19338235.294117644
P/E ratio: 39.40237651711027
P/B ratio: 1.0356611057365581
Pays dividend: no
Net asset value (USD): 20808823.529411763
Net cash (USD): -522720588.23529404
Net cash to market cap %: -68.6009846112017
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.3844138517758087 (Distress Zone)
Piotroski F-score: 4 (Weak)
MDA.TO — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Industrials | Industry: Aerospace & Defense
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 1413112503.2727273
Net income (USD): 36969696.96969697
EPS growth %: 91.17409839843302
Revenue growth %: 29.768048545341113
Smoothed growth %: 91.17409839843302
P/E ratio: 38.22353492459016
P/B ratio: 1.7519568933220626
PEG ratio: 0.41923677443512947
Pays dividend: no
Net asset value (USD): 32121212.12121212
Net cash (USD): -814015151.5151515
Net cash to market cap %: -57.60441221982795
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.5964412214453785 (Distress Zone)
Piotroski F-score: 6 (Neutral)
MDA.TO — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Industrials | Industry: Aerospace & Defense
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 3343686876.7342663
Net income (USD): 55524475.52447553
EPS growth %: 50.18915510718791
Revenue growth %: 23.45410904103328
EPS 2-year CAGR %: 69.44697199076491
Smoothed growth %: 69.44697199076491
P/E ratio: 60.220053321536525
P/B ratio: 4.065877749770409
PEG ratio: 0.8671372069259494
Pays dividend: no
Net asset value (USD): 108391608.3916084
Net cash (USD): -877482517.4825175
Net cash to market cap %: -26.242963226854027
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.429881232364978 (Grey Zone)
Piotroski F-score: 7 (Neutral)
MDA.TO — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Industrials | Industry: Aerospace & Defense
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 3148559062.948905
Net income (USD): 79197080.29197079
EPS growth %: 42.63454007244108
Revenue growth %: 57.83047933517913
EPS 2-year CAGR %: 46.36311373629034
Smoothed growth %: 46.36311373629034
P/E ratio: 39.75599922801844
P/B ratio: 3.183413960324724
PEG ratio: 0.857492002244443
Pays dividend: no
Net asset value (USD): -235109489.05109486
Net cash (USD): -1349781021.8978102
Net cash to market cap %: -42.86980154768386
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.7867148550704526 (Distress Zone)
Piotroski F-score: 6 (Neutral)
MDCX — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
MDCX — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: Low)
Market cap (USD): 137679338.52
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
MDCX — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 210768370.08
Net income (USD): -5102408
P/B ratio: 98.1434553356982
Pays dividend: no
Net asset value (USD): 2147554
Net cash (USD): 472118
Net cash to market cap %: 0.22399850595267268
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 24.99256620703874 (Safe Zone)
Piotroski F-score: 2 (Weak)
MDCX — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Speculative (confidence: Low)
Market cap (USD): 169407910.36
Net income (USD): -6176084
P/B ratio: 52.1462089136919
Pays dividend: no
Net asset value (USD): 3248710
Net cash (USD): 983628
Net cash to market cap %: 0.5806269600455746
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.57173499778294 (Safe Zone)
Piotroski F-score: 3 (Weak)
MDCX — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Turnaround (confidence: High)
Market cap (USD): 131446940.47999999
Net income (USD): -15981312
Pays dividend: no
Net asset value (USD): -910126
Net cash (USD): -2120460
Net cash to market cap %: -1.6131680146048235
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -5.773591057632249 (Distress Zone)
Piotroski F-score: 2 (Weak)
MDCX — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Turnaround (confidence: High)
Market cap (USD): 86686990.92
Net income (USD): -8184411
P/B ratio: 2323.362839913162
Pays dividend: no
Net asset value (USD): -67554
Net cash (USD): -1318848
Net cash to market cap %: -1.5213909099891503
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -6.325918953135298 (Distress Zone)
Piotroski F-score: 5 (Neutral)
MDCX — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Turnaround (confidence: High)
Market cap (USD): 20963520
Net income (USD): -9042143
P/B ratio: 18.252584183419778
Pays dividend: no
Net asset value (USD): 1326056
Net cash (USD): 366607
Net cash to market cap %: 1.748785509303781
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -15.342882251237814 (Distress Zone)
Piotroski F-score: 4 (Weak)
MDGL — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Medium)
Market cap (USD): 4892871952.98
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
MDGL — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Medium)
Market cap (USD): 7114284697.63
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
MDGL — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 7636725930.570001
Net income (USD): -73238000
P/B ratio: 10.746310606638833
Pays dividend: no
Net asset value (USD): 705998000
Net cash (USD): 557076000
Net cash to market cap %: 7.294696772736222
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 14.250407078266702 (Safe Zone)
Piotroski F-score: 1 (Weak)
MDGL — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 6977564639.759999
Net income (USD): -42281000
P/B ratio: 10.02555345105736
Pays dividend: no
Net asset value (USD): 691430000
Net cash (USD): 477621000
Net cash to market cap %: 6.845096027894745
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 11.473003228127189 (Safe Zone)
Piotroski F-score: 3 (Weak)
MDGL — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 10574708556.94
Net income (USD): -114190000
P/B ratio: 16.89974071477885
Pays dividend: no
Net asset value (USD): 618255000
Net cash (USD): 373024000
Net cash to market cap %: 3.527510928470844
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 7.300478429029459 (Safe Zone)
Piotroski F-score: 4 (Weak)
MDGL — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 13426232462.060001
Net income (USD): -58575000
P/B ratio: 22.277215051311707
Pays dividend: no
Net asset value (USD): 595308000
Net cash (USD): 326659000
Net cash to market cap %: 2.4329907956165417
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 10.929735284996505 (Safe Zone)
Piotroski F-score: 4 (Weak)
MDGL — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 12554037248
Net income (USD): -94391000
Revenue growth %: 126.83934426229509
Smoothed growth %: 126.83934426229509
P/B ratio: 22.20785166128136
Pays dividend: no
Net asset value (USD): 536170000
Net cash (USD): 128898000
Net cash to market cap %: 1.0267454003335454
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 9.351728105015749 (Safe Zone)
Piotroski F-score: 1 (Weak)
MDO.DE — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Consumer Cyclical | Industry: Restaurants
Lynch category:  (confidence: Medium)
Market cap (USD): 171191542367.92044
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
MDO.DE — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Consumer Cyclical | Industry: Restaurants
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 172539545142.47873
Net income (USD): 6177000000
P/E ratio: 27.93257975432714
Pays dividend: no
Net asset value (USD): -8903800000
Net cash (USD): -53855200000
Net cash to market cap %: -31.21325024679285
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.662191356348977 (Safe Zone)
Piotroski F-score: 4 (Weak)
MDO.DE — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Consumer Cyclical | Industry: Restaurants
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 197228531948.85556
Net income (USD): 8469000000
EPS growth %: 37.105390966488585
Revenue growth %: 9.977568803381933
Smoothed growth %: 37.105390966488585
P/E ratio: 23.288290465090988
PEG ratio: 0.6276255244453187
Pays dividend: no
Net asset value (USD): -7746000000
Net cash (USD): -56275000000
Net cash to market cap %: -28.53288996472021
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.696036362578761 (Safe Zone)
Piotroski F-score: 7 (Neutral)
MDO.DE — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Consumer Cyclical | Industry: Restaurants
Lynch category: Stalwart (confidence: Medium)
Market cap (USD): 199111865882.05206
Net income (USD): 8224000000
EPS growth %: -2.892903530523084
Revenue growth %: 1.6669935281427732
EPS 2-year CAGR %: 15.38590220242746
Smoothed growth %: 15.38590220242746
P/E ratio: 24.211073186047187
PEG ratio: 1.573588137212218
Pays dividend: no
Net asset value (USD): -6941000000
Net cash (USD): -57894000000
Net cash to market cap %: -29.07611745966696
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.915687437106205 (Safe Zone)
Piotroski F-score: 7 (Neutral)
MDO.DE — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Consumer Cyclical | Industry: Restaurants
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 216035575598.29413
Net income (USD): 8563000000
EPS growth %: 4.122081712062257
Revenue growth %: 3.7229938271604937
EPS 2-year CAGR %: 0.553433722653085
Smoothed growth %: 0.553433722653085
P/E ratio: 25.22895896278105
PEG ratio: 45.58623359963845
Pays dividend: no
Net asset value (USD): -5144000000
Net cash (USD): -60532000000
Net cash to market cap %: -28.019459217474353
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.902578738110738 (Safe Zone)
Piotroski F-score: 6 (Neutral)
MDP.TO — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: High)
Market cap (USD): 79531133.296
Net income (USD): -2303200
P/B ratio: 5.587562759667266
Pays dividend: no
Net asset value (USD): -55567200
Net cash (USD): -89132000
Net cash to market cap %: -112.0718343950505
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.10129680606449021 (Distress Zone)
Piotroski F-score: 1 (Weak)
MDP.TO — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 37523535.4074074
Net income (USD): 904444.4444444444
Revenue growth %: 30.49228678751109
Smoothed growth %: 30.49228678751109
P/E ratio: 41.48793841113841
P/B ratio: 2.2566274411974336
Pays dividend: no
Net asset value (USD): -43116296.29629629
Net cash (USD): -93194074.07407406
Net cash to market cap %: -248.3616563903968
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.4285956120860261 (Distress Zone)
Piotroski F-score: 5 (Neutral)
MDP.TO — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: High)
Market cap (USD): 37480424.72794118
Net income (USD): -158518.5185185185
EPS growth %: -117.52661752661753
Revenue growth %: 4.586663706335115
Smoothed growth %: -117.52661752661753
P/B ratio: 1.6686532791188393
Pays dividend: no
Net asset value (USD): -32662222.22222222
Net cash (USD): -89003703.70370369
Net cash to market cap %: -237.46716946180325
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.7097558614419838 (Distress Zone)
Piotroski F-score: 6 (Neutral)
MDP.TO — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 53579278.92307692
Net income (USD): 1571328.6713286715
Revenue growth %: -9.537505500496627
EPS 2-year CAGR %: 31.808242640429295
Smoothed growth %: 31.808242640429295
P/E ratio: 34.0980724788607
P/B ratio: 1.469389349673014
PEG ratio: 1.0719885680047272
Pays dividend: no
Net asset value (USD): -20597902.0979021
Net cash (USD): -66938461.538461536
Net cash to market cap %: -124.93348713140433
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.6214584663209527 (Distress Zone)
Piotroski F-score: 6 (Neutral)
MDP.TO — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: High)
Market cap (USD): 114797720.86330935
Net income (USD): -1722302.1582733814
EPS growth %: -209.60801452296107
Revenue growth %: -5.669169940420301
Smoothed growth %: -5.669169940420301
P/B ratio: 2.016344293937538
Pays dividend: no
Net asset value (USD): -16899280.57553957
Net cash (USD): -66022302.158273384
Net cash to market cap %: -57.511857954816634
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.250267008629427 (Distress Zone)
Piotroski F-score: 7 (Neutral)
MDT — Peter Lynch category analysis (quarterly, as of 2024-10-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category:  (confidence: Medium)
Market cap (USD): 107933410420.79999
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
MDT — Peter Lynch category analysis (quarterly, as of 2025-01-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 110787911194.5
Net income (USD): 1357291666.6666667
P/E ratio: 20.4060619237759
P/B ratio: 2.14363387577789
Pays dividend: no
Net asset value (USD): -3767708333.3333335
Net cash (USD): -33787500000
Net cash to market cap %: -30.49746099164415
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.3657229247580025 (Grey Zone)
Piotroski F-score: 4 (Weak)
MDT — Peter Lynch category analysis (quarterly, as of 2025-04-30)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 104208478917.9
Net income (USD): 1205681818.1818182
P/E ratio: 21.60779016205278
P/B ratio: 1.9003535611686009
Pays dividend: no
Net asset value (USD): -6113636363.636364
Net cash (USD): -39157954545.454544
Net cash to market cap %: -37.57655322491071
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.0529257007543915 (Grey Zone)
Piotroski F-score: 5 (Neutral)
MDT — Peter Lynch category analysis (quarterly, as of 2025-07-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 111875949606
Net income (USD): 1203448275.862069
P/E ratio: 29.703510842315772
P/B ratio: 2.022148550001454
Pays dividend: no
Net asset value (USD): -6134482758.620689
Net cash (USD): -39905747126.43678
Net cash to market cap %: -35.66963879812878
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.1531483391334056 (Grey Zone)
Piotroski F-score: 6 (Neutral)
MDT — Peter Lynch category analysis (quarterly, as of 2025-10-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 113296799766.90001
Net income (USD): 1605813953.488372
P/E ratio: 21.089320311738053
P/B ratio: 1.9942945289218332
Pays dividend: no
Net asset value (USD): -4570930232.55814
Net cash (USD): -39723255813.95349
Net cash to market cap %: -35.06123376448516
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.211515649609323 (Grey Zone)
Piotroski F-score: 7 (Neutral)
MDT — Peter Lynch category analysis (quarterly, as of 2026-01-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 129553373679.9
Net income (USD): 1369047619.047619
EPS growth %: 0.8661330994408492
Revenue growth %: 24.278133829508647
Smoothed growth %: 0.8661330994408492
P/E ratio: 24.06269951792057
P/B ratio: 2.2120667105276035
PEG ratio: 27.781757253538473
Pays dividend: no
Net asset value (USD): -3859523809.5238094
Net cash (USD): -40364285714.28572
Net cash to market cap %: -31.15649138865164
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.385891899663458 (Grey Zone)
Piotroski F-score: 7 (Neutral)
MDT — Peter Lynch category analysis (quarterly, as of 2026-04-30)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 106512556032
Net income (USD): 1463953488.372093
EPS growth %: 21.42121298467877
Revenue growth %: 12.412566006966061
Smoothed growth %: 21.42121298467877
P/E ratio: 21.514745308310992
P/B ratio: 1.7643057754403662
PEG ratio: 1.0043663411450658
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): -3802325581.395349
Net cash (USD): -39227906976.74419
Net cash to market cap %: -36.82937339796708
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.1168196068065463 (Grey Zone)
Piotroski F-score: 8 (Strong)
MDTBS.PA — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Lynch category:  (confidence: Low)
Pays dividend: no
Net asset value (USD): -37493750
Net cash (USD): -52139583.333333336
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
MDTBS.PA — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Lynch category:  (confidence: Low)
Pays dividend: no
Net asset value (USD): -43435294.11764706
Net cash (USD): -61898823.52941176
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
MEDICAMEQ.NS — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 113755584.44085455
Net income (USD): 1964618.2249769222
P/E ratio: 57.90213233015834
P/B ratio: 5.889331355324685
Pays dividend: no
Net asset value (USD): 19268073.32190426
Net cash (USD): -9943162.336806014
Net cash to market cap %: -8.740812493452404
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 8.016621689768696 (Safe Zone)
Piotroski F-score: 2 (Weak)
MEDICAMEQ.NS — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 108129170.8903776
Net income (USD): 1808051.157125457
EPS growth %: -7.96933805565732
Revenue growth %: 12.702134429498981
Smoothed growth %: -7.96933805565732
P/E ratio: 59.80426519694693
P/B ratio: 4.589843723958078
Pays dividend: no
Net asset value (USD): 23449013.398294766
Net cash (USD): -7834872.107186359
Net cash to market cap %: -7.2458449858359035
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 7.75136322192311 (Safe Zone)
Piotroski F-score: 4 (Weak)
MEDICAMEQ.NS — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 62139039.16506718
Net income (USD): 1310828.6365271616
EPS growth %: -27.50046748615278
Revenue growth %: 25.3181546547964
EPS 2-year CAGR %: -18.31658694750351
Smoothed growth %: -27.50046748615278
P/E ratio: 47.40439553540346
P/B ratio: 2.5034613603609515
Pays dividend: no
Net asset value (USD): 24486701.043290563
Net cash (USD): -8727785.106127834
Net cash to market cap %: -14.045574607201763
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.091368855849322 (Safe Zone)
Piotroski F-score: 3 (Weak)
MEDICAMEQ.NS — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 75745369.89613724
Net income (USD): 830979.6586392331
EPS growth %: -36.60653761419299
Revenue growth %: -11.625104346714519
EPS 2-year CAGR %: -32.206221617281386
Smoothed growth %: -36.60653761419299
P/E ratio: 91.15189416329844
P/B ratio: 3.0411488882651634
Pays dividend: no
Net asset value (USD): 24680009.352349777
Net cash (USD): -9391875.146130463
Net cash to market cap %: -12.399272931149047
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 6.0477363205953445 (Safe Zone)
Piotroski F-score: 4 (Weak)
MEDICAMEQ.NS — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 34762260.61890632
Net income (USD): 1038194.1500635863
EPS growth %: 24.936168926646936
Revenue growth %: 10.296460449787775
EPS 2-year CAGR %: -11.004852236325702
Smoothed growth %: 24.936168926646936
P/E ratio: 0.32586200203893595
P/B ratio: 1.0942319048343492
Dividend yield: 0.00
Pays dividend: no
Net asset value (USD): 29141415.854175497
Net cash (USD): -6906973.293768547
Net cash to market cap %: -19.869171828290185
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.1202910059209152 (Safe Zone)
Piotroski F-score: 5 (Neutral)
MEL.AX — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Energy | Industry: Oil & Gas E&P
Lynch category: Cyclical (confidence: High)
Market cap (USD): 288174.50980392157
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
MELG.OL — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category:  (confidence: Low)
Market cap (USD): 35836983.110687025
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
MELG.OL — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category:  (confidence: Low)
Market cap (USD): 34727484.275132276
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
MELG.OL — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Asset Play (confidence: High)
Market cap (USD): 41216497.77099237
Net income (USD): 2717366.4122137404
P/E ratio: 3.7919525303743242
P/B ratio: 0.2725915840265153
Pays dividend: no
Net asset value (USD): 150856011.45038167
Net cash (USD): -931339026.7175572
Net cash to market cap %: -2259.626792873754
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 4 (Weak)
MELG.OL — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Asset Play (confidence: High)
Market cap (USD): 45977403.360476665
Net income (USD): 4776464.746772592
P/E ratio: 6.135366861760986
P/B ratio: 0.2897061604798064
Pays dividend: no
Net asset value (USD): 158376861.96623635
Net cash (USD): -1033798013.9026812
Net cash to market cap %: -2248.491516141949
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 6 (Neutral)
MELG.OL — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Asset Play (confidence: High)
Market cap (USD): 43795253.18036072
Net income (USD): 2855110.220440882
P/E ratio: 4.2318582717476625
P/B ratio: 0.2664571717695142
Pays dividend: no
Net asset value (USD): 164065831.66332665
Net cash (USD): -1041349899.7995992
Net cash to market cap %: -2377.7688771681214
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
MELG.OL — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Asset Play (confidence: High)
Market cap (USD): 51782509.68326694
Net income (USD): 3489751.2437810944
P/E ratio: 3.7418642853895463
P/B ratio: 0.30558028269327997
Pays dividend: no
Net asset value (USD): 169196716.41791043
Net cash (USD): -1029790248.7562189
Net cash to market cap %: -1988.683544028741
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 4 (Weak)
MELG.OL — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Asset Play (confidence: High)
Market cap (USD): 53264259.81500514
Net income (USD): 2785200.4110996914
EPS growth %: 2.4963140260017087
Revenue growth %: 1.7363579114945165
Smoothed growth %: 2.4963140260017087
P/E ratio: 1.3764498605197473
P/B ratio: 0.30060112720569476
PEG ratio: 0.551392912182758
Dividend yield: 0.07
Pays dividend: yes
Net asset value (USD): 177452004.1109969
Net cash (USD): -1093295683.4532373
Net cash to market cap %: -2052.587771331882
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 5 (Neutral)
MENE.V — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Consumer Cyclical | Industry: Luxury Goods
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 94751598.74015749
Net income (USD): -25701.574803149604
P/B ratio: 6.829110312169903
Pays dividend: no
Net asset value (USD): 12685406.2992126
Net cash (USD): -2491131.496062991
Net cash to market cap %: -2.6291181670660335
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 6.677341040135439 (Safe Zone)
Piotroski F-score: 0 (Weak)
MENE.V — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Consumer Cyclical | Industry: Luxury Goods
Lynch category: Speculative (confidence: Low)
Market cap (USD): 55300795.22058823
Net income (USD): -1076078.6764705882
Revenue growth %: -6.13487337034579
Smoothed growth %: -6.13487337034579
P/B ratio: 4.30525725786167
Pays dividend: no
Net asset value (USD): 11851518.38235294
Net cash (USD): -714873.5294117648
Net cash to market cap %: -1.29270027051188
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.672212496139129 (Safe Zone)
Piotroski F-score: 4 (Weak)
MENE.V — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Consumer Cyclical | Industry: Luxury Goods
Lynch category: Speculative (confidence: Low)
Market cap (USD): 34185946.13636363
Net income (USD): -1505862.121212121
Revenue growth %: -10.835691443207002
Smoothed growth %: -10.835691443207002
P/B ratio: 2.8235615340699907
Pays dividend: no
Net asset value (USD): 11725426.515151514
Net cash (USD): 4559384.848484848
Net cash to market cap %: 13.337015246844446
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 12.416537488065593 (Safe Zone)
Piotroski F-score: 6 (Neutral)
MENE.V — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Consumer Cyclical | Industry: Luxury Goods
Lynch category: Speculative (confidence: Low)
Market cap (USD): 12622503.188811189
Net income (USD): -695058.041958042
Revenue growth %: 2.2556306146147573
Smoothed growth %: 2.2556306146147573
P/B ratio: 1.0157699135771296
Pays dividend: no
Net asset value (USD): 12143378.321678322
Net cash (USD): 3002153.846153846
Net cash to market cap %: 23.784140128520693
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.7443922392882545 (Safe Zone)
Piotroski F-score: 5 (Neutral)
MENE.V — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Consumer Cyclical | Industry: Luxury Goods
Lynch category:  (confidence: Low)
Market cap (USD): 16469141.934306568
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
MER.L — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Consumer Cyclical | Industry: Personal Services
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 1660229.1087837839
Pays dividend: no
Net cash (USD): 73827027.02702703
Net cash to market cap %: 4446.797531523206
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
MER.L — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Consumer Cyclical | Industry: Personal Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 1699847.4792771086
Net income (USD): 34936144.578313254
P/E ratio: 0.04865584052833052
P/B ratio: 0.0065982621667251265
Pays dividend: no
Net asset value (USD): 100015662.65060242
Net cash (USD): -381854216.8674699
Net cash to market cap %: -22464.02818621471
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.020983022299167 (Grey Zone)
Piotroski F-score: 4 (Weak)
MER.L — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Consumer Cyclical | Industry: Personal Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 2779205.9021518985
Net income (USD): 46405063.29113924
EPS growth %: 32.82823234005437
Revenue growth %: 19.265036787575223
Smoothed growth %: 32.82823234005437
P/E ratio: 0.0598901435542826
P/B ratio: 0.010952890722652351
PEG ratio: 0.0018243487171013305
Pays dividend: no
Net asset value (USD): 86827848.10126582
Net cash (USD): -447731645.56962025
Net cash to market cap %: -16110.056661255223
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.159401085662326 (Grey Zone)
Piotroski F-score: 6 (Neutral)
MER.L — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Consumer Cyclical | Industry: Personal Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 3319119.323125
Net income (USD): 58670000
EPS growth %: 26.43016912165849
Revenue growth %: 2.664638350100576
EPS 2-year CAGR %: 29.589721347350782
Smoothed growth %: 29.589721347350782
P/E ratio: 0.05657268319626726
P/B ratio: 0.014164219766356387
PEG ratio: 0.0019119032089611858
Pays dividend: no
Net asset value (USD): 69993750
Net cash (USD): -528095000
Net cash to market cap %: -15910.696440488036
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.2470622492940198 (Grey Zone)
Piotroski F-score: 7 (Neutral)
MER.L — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Consumer Cyclical | Industry: Personal Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 465399697.2972973
Net income (USD): 62462162.16216216
EPS growth %: 6.463545529507692
Revenue growth %: 8.389807189817788
EPS 2-year CAGR %: 16.01811956150232
Smoothed growth %: 16.01811956150232
P/E ratio: 0.08683683683683684
P/B ratio: 0.013428427495850014
PEG ratio: 0.005421162983796115
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 99789189.1891892
Net cash (USD): -657847297.2972972
Net cash to market cap %: -141.35103677926642
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.537676382914376 (Grey Zone)
Piotroski F-score: 5 (Neutral)
MERC.L — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Turnaround (confidence: High)
Market cap (USD): 1665314.0407894738
Net income (USD): 34342105.2631579
P/E ratio: 0.048491903103448274
P/B ratio: 0.0063096115489882304
Pays dividend: no
Net asset value (USD): 221360526.31578946
Net cash (USD): 61936842.10526316
Net cash to market cap %: 3719.2289615177215
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.8036152633366065 (Distress Zone)
Piotroski F-score: 2 (Weak)
MERC.L — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: High)
Market cap (USD): 1250013.502222222
Net income (USD): 3501234.567901234
EPS growth %: -89.8048342084102
Revenue growth %: 4.746613498716332
Smoothed growth %: -89.8048342084102
P/E ratio: 0.35702078166431594
P/B ratio: 0.004989680401732693
Pays dividend: no
Net asset value (USD): 202019753.08641973
Net cash (USD): 27574074.074074075
Net cash to market cap %: 2205.902098261661
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.6920039357701393 (Distress Zone)
Piotroski F-score: 5 (Neutral)
MERC.L — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Turnaround (confidence: High)
Market cap (USD): 1655476.7426582277
Net income (USD): -9601265.82278481
EPS growth %: -374.22515220224597
Revenue growth %: 20.56907002302163
Smoothed growth %: 20.56907002302163
P/B ratio: 0.006910905283210298
Pays dividend: no
Net asset value (USD): 193601265.8227848
Net cash (USD): 39587341.7721519
Net cash to market cap %: 2391.295555658838
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.745117096951088 (Distress Zone)
Piotroski F-score: 5 (Neutral)
MERC.L — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: High)
Market cap (USD): 1369738.8214285714
Net income (USD): 4487012.987012987
Revenue growth %: 18.66764700108986
EPS 2-year CAGR %: 13.205638734683367
Smoothed growth %: 13.205638734683367
P/E ratio: 0.3052674073806078
P/B ratio: 0.00561287707482957
PEG ratio: 0.02311644393079236
Pays dividend: no
Net asset value (USD): 200779220.77922076
Net cash (USD): 31832467.532467533
Net cash to market cap %: 2323.980822801518
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.7745722688901078 (Distress Zone)
Piotroski F-score: 6 (Neutral)
MERG.V — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Basic Materials | Industry: Other Industrial Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 29452097.007874016
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
MERG.V — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Basic Materials | Industry: Other Industrial Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 7563341.823529411
Net income (USD): -3510309.558823529
P/B ratio: 4.27010853212624
Pays dividend: no
Net asset value (USD): 1771229.4117647058
Net cash (USD): 1487722.7941176472
Net cash to market cap %: 19.670177929673496
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.06946613187841244 (Distress Zone)
Piotroski F-score: 2 (Weak)
MERG.V — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Basic Materials | Industry: Other Industrial Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 7792534
Net income (USD): -1268081.8181818181
P/B ratio: 5.847550203177621
Pays dividend: no
Net asset value (USD): 1332615.1515151514
Net cash (USD): 1250906.0606060605
Net cash to market cap %: 16.05262242816086
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 64.2236631994625 (Safe Zone)
Piotroski F-score: 4 (Weak)
MERG.V — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Basic Materials | Industry: Other Industrial Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 5558310.965034965
Net income (USD): -4304269.230769231
Pays dividend: no
Net asset value (USD): -2201463.6363636362
Net cash (USD): -2256483.916083916
Net cash to market cap %: -40.596575655419834
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -29.766229323040164 (Distress Zone)
Piotroski F-score: 2 (Weak)
MERG.V — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Basic Materials | Industry: Other Industrial Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 21841847.12408759
Net income (USD): -1536020.4379562042
P/B ratio: 12.288776511665441
Pays dividend: no
Net asset value (USD): 1777381.7518248174
Net cash (USD): 1678190.5109489048
Net cash to market cap %: 7.683372662645209
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -0.24570308609068503 (Distress Zone)
Piotroski F-score: 4 (Weak)
META — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Communication Services | Industry: Internet Content & Information
Lynch category:  (confidence: Medium)
Market cap (USD): 1249923267321.96
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
META — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Communication Services | Industry: Internet Content & Information
Lynch category:  (confidence: Medium)
Market cap (USD): 1279482040936.44
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
META — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Communication Services | Industry: Internet Content & Information
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 1260618009335.52
Net income (USD): 16644000000
P/E ratio: 18.93502176963951
P/B ratio: 6.813083404955547
Pays dividend: no
Net asset value (USD): 164375000000
Net cash (USD): -24954000000
Net cash to market cap %: -1.9795052756031477
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 9.051660164713391 (Safe Zone)
Piotroski F-score: 4 (Weak)
META — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Communication Services | Industry: Internet Content & Information
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 1615586818179.8398
Net income (USD): 18337000000
P/E ratio: 46.184695068175294
P/B ratio: 8.282087548981595
Pays dividend: no
Net asset value (USD): 174416000000
Net cash (USD): -52603000000
Net cash to market cap %: -3.2559686305972613
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 10.76824518755857 (Safe Zone)
Piotroski F-score: 8 (Strong)
META — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Communication Services | Industry: Internet Content & Information
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 1608537511842.36
Net income (USD): 2709000000
P/E ratio: 42.67809795283524
P/B ratio: 8.28861063680583
Pays dividend: no
Net asset value (USD): 172908000000
Net cash (USD): -65330000000
Net cash to market cap %: -4.06145330892367
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 9.794096133034385 (Safe Zone)
Piotroski F-score: 7 (Neutral)
META — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Communication Services | Industry: Internet Content & Information
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 1446996398389.0798
Net income (USD): 22768000000
P/E ratio: 23.93391111828178
P/B ratio: 6.6607273808089555
Pays dividend: no
Net asset value (USD): 189017000000
Net cash (USD): -67186000000
Net cash to market cap %: -4.643135261068874
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 6.905041632798709 (Safe Zone)
Piotroski F-score: 6 (Neutral)
META — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Communication Services | Industry: Internet Content & Information
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 1510844137472
Net income (USD): 26773000000
EPS growth %: 60.85676520067291
Revenue growth %: 33.07888642057002
Smoothed growth %: 60.85676520067291
P/E ratio: 20.785454545454545
P/B ratio: 5.151241410289682
PEG ratio: 0.34154714725495655
Dividend yield: 0.00
Pays dividend: no
Net asset value (USD): 218933000000
Net cash (USD): -70389000000
Net cash to market cap %: -4.658918696787444
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 7.017904614985272 (Safe Zone)
Piotroski F-score: 7 (Neutral)
METN.SW — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 310312319.2
P/B ratio: 0.5741727842172999
Pays dividend: no
Net asset value (USD): 463898888.8888889
Net cash (USD): -143664444.44444445
Net cash to market cap %: -46.29672609028809
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
METN.SW — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 330534750
P/B ratio: 0.5769791205266455
Pays dividend: no
Net asset value (USD): 487911250
Net cash (USD): -217715000
Net cash to market cap %: -65.86750712292732
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
METN.SW — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Asset Play (confidence: High)
Market cap (USD): 418993296.20253164
P/B ratio: 0.4572641697522073
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 484362025.31645566
Net cash (USD): -255087341.7721519
Net cash to market cap %: -60.88100790253422
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
MF.PA — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category:  (confidence: Medium)
Market cap (USD): 3714998352.295455
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
MF.PA — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 2990024667.8723407
Net income (USD): 1087340425.531915
P/E ratio: 2.7498514703062322
P/B ratio: 0.6062211651101094
Pays dividend: no
Net asset value (USD): -3032872340.425532
Net cash (USD): -6818723404.25532
Net cash to market cap %: -228.04906854188022
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.1294942413415774 (Distress Zone)
Piotroski F-score: 4 (Weak)
MF.PA — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 2984502923.3333335
Net income (USD): 589888888.8888888
EPS growth %: -45.74938307841156
Revenue growth %: 10.407302561264999
Smoothed growth %: -45.74938307841156
P/E ratio: 5.059432343190809
P/B ratio: 0.5559343966801887
Pays dividend: no
Net asset value (USD): -3424111111.111111
Net cash (USD): -8666888888.888887
Net cash to market cap %: -290.396394693727
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.42499241935 (Distress Zone)
Piotroski F-score: 7 (Neutral)
MF.PA — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 3367703366.6145835
Net income (USD): 1031145833.3333334
EPS growth %: 74.8033998869844
Revenue growth %: -5.930590412629861
EPS 2-year CAGR %: -2.618316486825789
Smoothed growth %: 74.8033998869844
P/E ratio: 3.265981646580463
P/B ratio: 0.6255795727457433
Pays dividend: no
Net asset value (USD): -3056666666.666667
Net cash (USD): -7065520833.333334
Net cash to market cap %: -209.80235086548066
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.3604901013982136 (Distress Zone)
Piotroski F-score: 7 (Neutral)